Structure-activity relationships of competitive NMDA receptor antagonists

被引:5
作者
Cheung, NS
OCallaghan, D
Ryan, MC
Dutton, R
Wong, MG
Beart, PM
机构
[1] MONASH UNIV,DEPT PHARMACOL,CLAYTON,VIC 3168,AUSTRALIA
[2] UNIV MELBOURNE,AUSTIN HOSP,DEPT MED,HEIDELBERG,VIC 3084,AUSTRALIA
[3] SWINBURNE UNIV TECHNOL,DEPT APPL CHEM,HAWTHORN,VIC 3122,AUSTRALIA
关键词
NMDA receptor; competitive antagonist; radioligand binding; neuroprotection; molecular modelling;
D O I
10.1016/0014-2999(96)00608-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction of structurally constrained competitive NMDA receptor antagonists, (+/-)-cis-4-phosphonomethyl-2-piperidine carboxylic acid (CGS 19755), (2-amino-4,5-(1,2-cyclohexyl))-7-phosphonoheptanoic acid (NPC 12626), (+/-)-6-phosphonomethyl-decahydroisoquinoline-3-carboxylic acid (LY 274614), (S)-alpha-amino-5-phosphonomethyl[1,1'-biphenyl]-3-propanoic acid (SDZ EAB-515) and (S)-alpha-amino-5-phosphonomethyl[1,1':4',1 ''-terphenyl]-3-propanoic acid (SDZ 215-439), with their receptor was assessed using radioligand binding, protection against neurotoxicity in cortical neuronal cultures and computerised molecular modelling. All compounds inhibited the specific binding of [H-3]CGS 19755 and/or [H-3]CGP 39653 (inhibition constants 40-2000 nM), and protected neuronal cultures from NMDA-mediated injury (IC50 values 1.3-5.6 mu M). Quantitative conformational analyses indicated that the molecules fitted well to a NMDA receptor model. Our results draw attention to a deep hydrophobic pocket, defined by the bi- and terphenyl containing antagonists (SDZ EAB-515, SDZ 215-439), which may influence potency and selectivity.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [41] Emerging screening platform characterises aminoquinoline structure-activity relationships with phospholipid layers
    Crow, Bethany
    Grafstrom, Roland
    Hongisto, Vesa
    Kamat, Mitali
    Kapur, Nikil
    Kelly, Ross
    Owen, Josh
    Rashid, Ashi
    Stokes, William
    William, Nicola
    Williams, Jeanine
    Nelson, Andrew
    BIOELECTROCHEMISTRY, 2025, 164
  • [42] Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions
    Jansen, M
    Dannhardt, G
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (7-8) : 661 - 670
  • [43] Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites
    Wenk, GL
    Baker, LM
    Stoehr, JD
    Hauss-Wegrzyniak, B
    Danysz, W
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (2-3) : 183 - 187
  • [44] NMDA AND NON-NMDA RECEPTOR GENE-EXPRESSION FOLLOWING GLOBAL BRAIN ISCHEMIA IN RATS - EFFECT OF NMDA AND NON-NMDA RECEPTOR ANTAGONISTS
    PELLEGRINIGIAMPIETRO, DE
    PULSINELLI, WA
    ZUKIN, RS
    JOURNAL OF NEUROCHEMISTRY, 1994, 62 (03) : 1067 - 1073
  • [45] Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - Preclinical studies
    Danysz, W
    Parsons, CG
    Kornhuber, J
    Schmidt, WJ
    Quack, G
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04) : 455 - 468
  • [46] Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues
    Marshall, NJ
    Andruszkiewicz, R
    Gupta, S
    Milewski, S
    Payne, JW
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 821 - 831
  • [47] Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
    Bartsch, Caitlyn J.
    Nordman, Jacob C.
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [48] Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test
    Lutfy, K
    Shen, KZ
    Woodward, RM
    Weber, E
    BRAIN RESEARCH, 1996, 731 (1-2) : 171 - 181
  • [49] QUISQUALIC ACID-INDUCED NEUROTOXICITY IS PROTECTED BY NMDA AND NON-NMDA RECEPTOR ANTAGONISTS
    PAI, KS
    RAVINDRANATH, V
    NEUROSCIENCE LETTERS, 1992, 143 (1-2) : 177 - 180
  • [50] Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia
    Tomoki Nishiyama
    Canadian Journal of Anaesthesia, 2000, 47 : 693 - 698